Calvert US Select Equity ETF (CVSE)
NYSEARCA: CVSE · Real-Time Price · USD
71.05
+0.58 (0.82%)
At close: Jun 30, 2025, 4:00 PM
71.05
0.00 (0.00%)
After-hours: Jun 30, 2025, 4:10 PM EDT
0.82% (1D)
| Assets | $13.33M |
| Expense Ratio | 0.29% |
| PE Ratio | 24.68 |
| Shares Out | 190,000 |
| Dividend (ttm) | $0.79 |
| Dividend Yield | 1.12% |
| Ex-Dividend Date | Jun 23, 2025 |
| Payout Ratio | 27.74% |
| 1-Year Return | +9.97% |
| Volume | 323 |
| Open | 70.83 |
| Previous Close | 70.47 |
| Day's Range | 70.62 - 71.05 |
| 52-Week Low | 56.89 |
| 52-Week High | 71.77 |
| Beta | 1.06 |
| Holdings | 170 |
| Inception Date | Jan 30, 2023 |
About CVSE
Fund Home PageThe Calvert US Select Equity ETF (CVSE) is an exchange-traded fund that mostly invests in large cap equity. The fund is an actively managed fund of select US large-cap companies that supports sustainability through global environmental or societal activities and are considered leaders in managing financially material ESG factors. CVSE was launched on Jan 30, 2023 and is issued by Morgan Stanley.
Asset Class Equity
Category Large Blend
Region North America
Stock Exchange NYSEARCA
Ticker Symbol CVSE
ETF Provider Morgan Stanley
Top 10 Holdings
34.79% of assets| Name | Symbol | Weight |
|---|---|---|
| Microsoft Corporation | MSFT | 7.59% |
| NVIDIA Corporation | NVDA | 7.44% |
| Apple Inc. | AAPL | 5.34% |
| Netflix, Inc. | NFLX | 2.55% |
| Parker-Hannifin Corporation | PH | 2.13% |
| Boston Scientific Corporation | BSX | 2.06% |
| S&P Global Inc. | SPGI | 1.95% |
| Visa Inc. | V | 1.94% |
| Capital One Financial Corporation | COF | 1.94% |
| Eli Lilly and Company | LLY | 1.84% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jun 23, 2025 | $0.2604 | Jun 27, 2025 |
| Mar 24, 2025 | $0.16372 | Mar 28, 2025 |
| Dec 23, 2024 | $0.21165 | Dec 27, 2024 |
| Sep 23, 2024 | $0.15639 | Sep 27, 2024 |
| Jun 24, 2024 | $0.20333 | Jun 28, 2024 |
| Mar 18, 2024 | $0.13817 | Mar 22, 2024 |
